Ralf J. Hosse

A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors

Marina Bacac, Tanja Fauti, Johannes Sam et al. · Clinical Cancer Research · 2016 · 355 citations · Full text

Pharmacy, Immunology, Oncology +17

Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment

Anja Seckinger, Jose Antonio Delgado, Samuel Moser et al. · Cancer Cell · 2017 · 312 citations · Full text

Medicine, Oncology, Pharmacology +17

Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy

Christina Claus, Claudia Ferrara, Wei Xu et al. · Science Translational Medicine · 2019 · 266 citations · Full text

Medicine, Immunology, Oncology +17

A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease

Laurence B. Peterson, Sarah Howlett, Marcin Ł. Pękalski et al. · Journal of Autoimmunity · 2018 · 150 citations · Full text

Life Sciences, Immunology, Molecular Medicine +16

RG7386, a Novel Tetravalent FAP-DR5 Antibody, Effectively Triggers FAP-Dependent, Avidity-Driven DR5 Hyperclustering and Tumor Cell Apoptosis

Peter Brünker, Katharina Wartha, Thomas Friess et al. · Molecular Cancer Therapeutics · 2016 · 131 citations · Full text

Life Sciences, Cancer Biology, Cell Biology +17